N. Ferrentino

发表

Severe hepatotoxicity associated with bromfenac sodium

P. Moses, B. Schroeder, O. Alkhatib, 1999, American Journal of Gastroenterology.

Inflammatory bowel disease. 1. Origins, presentation, and course.

B. R. Moore, P. Moses, N. Ferrentino, 1998, Postgraduate medicine.

Frequency of Inappropriate Continuation of Acid Suppressive Therapy After Discharge in Patients Who Began Therapy in the Surgical Intensive Care Unit

N. Ferrentino, B. Crookes, C. Freiburg, 2008, Pharmacotherapy.

Health-related quality of life (HRQOL) subsequent to esophageal adenocarcinoma staging with endoscopic ultrasound (EUS)

P. Moses, N. Ferrentino, R. Zubarik, 2003, American Journal of Gastroenterology.

Angiotensin receptor antagonists in portal hypertension: fog over paradise.

N. Ferrentino, Christian A. Speer, 2002, Gastroenterology.

Russell Body Inflammatory Polyp

N. Ferrentino, Michelle X. Yang, Ryan F. Coates, 2017, International journal of surgical pathology.

Procedure-related abdominal discomfort in patients undergoing colorectal cancer screening: a comparison of colonoscopy and flexible sigmoidoscopy

P. Moses, N. Ferrentino, E. Ganguly, 2002, American Journal of Gastroenterology.

Peginterferon alfa-2b and ribavirin for treatment-refractory chronic hepatitis C.

T. Ashikaga, S. Gordon, N. Ferrentino, 2005, Journal of hepatology.

Utility of laboratory monitoring during hepatitis C treatment with ribavirin‐free direct‐acting antiviral regimens

D. Strader, N. Ferrentino, S. Lidofsky, 2019, Journal of viral hepatitis.

Serotonin signaling in the mucosa of the human colon

M. Crowell, D. R. Linden, M. Coates, 2003 .